Final Results.
Highlights
Revenue increased to 4,511,000 (2009: 4,312,000)
Retained profit at Group level lower at 525,000 (2008: 630,000) due principally to unavoidable third party issues, now resolved, which resulted in delay in the delivery of a major industrial devices order prior to year end and a write down of autologous blood transfusion assets, following a strategic review
EBITDA of core operating company increased by 11% to 1,103,000 (2008: 995,000)
Net cash of 1.4 million generated from operating activities
Continuing and significant investment in new product development in laparoscopic instrumentation
Major investment in state-of-art manufacturing facility and clean room
Employees more than doubled to reflect increased demand for products
Successfully launched LogiFlex to assist with the accurate placement of gastric bands
New laparoscopic training centre operational during the year and officially opened by Lord Davies of Abersoch, Minister for Trade Investment and Small Business
Largest ever order for industrial devices based on core technology
Negotiations during the year with major US Group Purchasing Organisation (GPO), Premier, successfully concluded in January 2010